Identifying novel prostate cancer associated pathways based on integrative microarray data analysis
- 27 April 2011
- journal article
- research article
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 35 (3) , 151-158
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31040020, 91029703)
- Major State Basic Research Development Program of China (2007CB947002, 2010CB945600)
This publication has 34 references indexed in Scilit:
- Association of vitamin D receptor polymorphisms with the risk of prostate cancer in the Han population of Southern ChinaBMC Medical Genetics, 2009
- Systems Biology Reveals New Strategies for Personalizing Cancer Medicine and Confirms the Role of PTEN in Resistance to TrastuzumabCancer Research, 2009
- GWAS Meets Microarray: Are the Results of Genome-Wide Association Studies and Gene-Expression Profiling Consistent? Prostate Cancer as an ExamplePLOS ONE, 2009
- Genomic outlier profile analysis: mixture models, null hypotheses, and nonparametric estimationBiostatistics, 2008
- Meta-analysis of microarray results: challenges, opportunities, and recommendations for standardizationGene, 2007
- Cancer: A Systems Biology diseaseBioSystems, 2006
- Outcome signature genes in breast cancer: is there a unique set?Bioinformatics, 2004
- Statistical issues and methods for meta-analysis of microarray data: a case study in prostate cancerFunctional & Integrative Genomics, 2003
- International Union of Pharmacology. XXIX. Update on Endothelin Receptor NomenclaturePharmacological Reviews, 2002
- Delineation of prognostic biomarkers in prostate cancerNature, 2001